Eltroxin-LF, 0.05 mg, Tabletten

7680298120210 CH-29812 Tabletten
Eltroxin-LF, 0.05 mg, Tabletten
Eltroxin-LF, 0.05 mg, Tabletten
Eltroxin-LF, 0.05 mg, Tabletten
1 / 3
google

Article details

Package size
100
Selling units
100
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
08/11/2023
Patient information leaflet
Français
08/11/2023
Patient information leaflet
Italien
08/11/2023
Summary of Product Characteristics
Allemand
15/09/2023
Summary of Product Characteristics
Français
15/09/2023
Summary of Product Characteristics
Italien
15/09/2023

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.4 UG Substance HBESI

Reimbursement information

Public price
CHF 15.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1993

Authorization holder

Alfasigma Schweiz AG

4800 Zofingen

Authorization information

Swissmedic authorization number
29812
Drug name
Eltroxin-LF, Tabletten
Galenic form
TAB
ATC Code
H03AA01
Authorization status
Z
Dispensing category
B
First authorization
15/08/1963
Authorization expiration date
31/12/9999
IT Number
07.04.2.
Domain
Human medicine
Field of application
Hypothyreose

Package details

Description (FR)
ELTROXINE LF cpr 0.05 mg bte 100 pce
Description (DE)
ELTROXIN LF Tabl 0.05 mg Ds 100 Stk
Market launch
20/05/2009
Narcotic (BTM)
No

Other package sizes (3)

ELTROXIN cpr 0.05 mg 100 pce
100 TABL
GTIN: 7680298120128
Not in V1
ELTROXIN cpr 0.1 mg 100 pce
100 TABL
GTIN: 7680298120203
Not in V1
ELTROXINE LF cpr 0.1 mg bte 100 pce
100 TABL
GTIN: 7680298120012
View